What is the diagnosis and treatment for a patient with chronic bronchitis, likely an older adult with a history of smoking?

Chronic Bronchitis: Diagnosis and Treatment

Diagnosis

Chronic bronchitis is diagnosed clinically when a patient has cough with sputum production occurring on most days for at least 3 months per year during 2 consecutive years, after excluding other respiratory or cardiac causes of chronic productive cough. 1

Key Diagnostic Criteria:

• Productive cough for ≥3 months per year for ≥2 consecutive years 1
• Exclusion of other cardiac or respiratory causes is essential before making this diagnosis 1
• Detailed exposure history is critical, including:
  • Cigarette, cigar, and pipe smoking (most significant risk factor worldwide) 1
  • Passive smoke exposure 1
  • Occupational and environmental irritants (biomass fuels, industrial pollutants, dusty environments) 1

Clinical Assessment:

• Pulmonary function testing to assess for airflow obstruction and stage COPD severity (post-bronchodilator FEV1/FVC ratio <70%) 1
• Evaluation for acute exacerbation if patient presents with increased dyspnea, increased sputum volume, or increased sputum purulence 1

---

Treatment of Stable Chronic Bronchitis

The single most effective intervention is complete avoidance of all respiratory irritants, particularly smoking cessation, which leads to resolution of cough in 90% of patients. 1

Primary Management:

• Smoking cessation is mandatory and should be encouraged at every visit 1
• Remove all environmental and occupational irritants 1

Pharmacologic Treatment for Stable Disease:

For chronic cough due to stable chronic bronchitis, there is insufficient evidence to recommend routine use of any pharmacologic treatments (antibiotics, bronchodilators, mucolytics) specifically for cough relief. 1

However, the following may provide symptomatic benefit:

Bronchodilators:

• Short-acting inhaled β-agonists (e.g., albuterol) may improve cough 1
• Inhaled ipratropium bromide may improve cough 1
• Combined long-acting β-agonist plus inhaled corticosteroid may improve cough in patients with airflow obstruction 1

Cough Suppressants:

• Codeine or dextromethorphan are recommended for short-term symptomatic relief of coughing 1

NOT Recommended for Stable Disease:

• Prophylactic antibiotics have no proven benefit 1
• Oral corticosteroids have no proven benefit 1
• Expectorants have no proven benefit 1
• Postural drainage and chest physiotherapy have no proven benefit 1

---

Treatment of Acute Exacerbations

An acute exacerbation is characterized by increased dyspnea, increased sputum volume, and/or increased sputum purulence. 1

Indications for Antibiotic Therapy:

Antibiotics should be reserved for patients with at least one cardinal symptom (increased dyspnea, increased sputum production, or increased sputum purulence) AND at least one risk factor. 2

Risk Factors for Antibiotic Use:

• Age ≥65 years 2
• FEV1 <50% predicted 2
• ≥4 exacerbations in 12 months 2
• One or more comorbidities 2

Treatment Regimen for Acute Exacerbations:

Bronchodilators:

• Inhaled bronchodilators (short-acting β-agonists and/or ipratropium) are effective 1

Corticosteroids:

• Oral corticosteroids are useful for acute exacerbations 1
• IV corticosteroids for severe cases 1

Antibiotics (when indicated):

• For moderate severity exacerbations: newer macrolide, extended-spectrum cephalosporin, or doxycycline 2
• For severe exacerbations: high-dose amoxicillin/clavulanate or respiratory fluoroquinolone 2
• Common bacterial pathogens: Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis 1, 3, 2
• In patients with severe underlying disease: consider Pseudomonas aeruginosa 3

NOT Recommended for Acute Exacerbations:

• Theophylline is not recommended 1
• Expectorants are not recommended 1
• Postural drainage and chest physiotherapy are not recommended 1

---

Important Clinical Caveats

Common Pitfalls:

• Overdiagnosis is common: 88.4% of patients with self-reported or physician-diagnosed chronic bronchitis do not meet standard criteria 1
• The term "bronchitis" is often misused for self-limited acute cough illnesses 1
• Bacterial colonization occurs in stable disease: isolating bacteria from sputum does not automatically indicate need for antibiotics 1

Prognostic Considerations:

• Persistent or newly developed chronic bronchitis is associated with:

  • Worse respiratory symptoms 4
  • Worse health-related quality of life 4
  • Greater exacerbation frequency 4
  • Shorter 6-minute walk distance 4
  • More rapid decline in lung function 4

• Quitting smoking confers an OR of 4.289 for resolution of chronic bronchitis 4

• Continued smoking confers an OR of 5.767 for persistent chronic bronchitis 4

Monitoring:

• Repeatedly assess for chronic cough and sputum production in all smokers to identify those at risk for poor outcomes 4
• Follow patients for at least 2 weeks after treatment of acute exacerbations to assess for relapse, recurrence, or complications 1